Contraception

Article	Citations
CHANGES IN BELIEFS ABOUT ABORTION SAFETY IN A NATIONALLY REPRESENTATIVE SAMPLE BETWEEN 2022 AND 2023	60
Editorial Board	49
PHARMACIST ATTITUDES TOWARDS ADMINISTRATION OF DEPOT-MEDROXYPROGESTERONE ACETATE FOR CONTRACEPTION IN THE OUTPATIENT SETTING	44
When doctors are “doxxed:” An analysis of information posted on an antiabortion website	42
Copyright info/Contents	39
THE INTERSECTION OF ENGLISH PROFICIENCY AND NATIVITY IN RECEIPT OF PERSON-CENTERED CONTRACEPTIVE COUNSELING	38
PREDICTORS OF ABORTION PROVISION AMONG OBSTETRICIAN-GYNECOLOGISTS IN MASSACHUSETTS	36
O20Trauma responsive abortion care (on trac study): The abortion experiences of patients with a history of trauma	34
P025Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment	31
P010Healthcare at the margins: The role of healthcare providers in self-managed abortion near the us-mexico border	30
Development of a Spanish-language drug facts label prototype for a combination mifepristone and misoprostol medication abortion product	28
ABORTION CARE PREFERENCES AND TRADE-OFFS WHEN TRAVELING OUT OF STATE FOR FACILITY-BASED SERVICES	28
Abortion research that matters: Using core outcomes to enable systematic review	28
P081And then what happened? Assessing contraceptive use outcomes over three years among participants in the her salt lake contraceptive initiative	26
Society of Family Planning Annual Meeting 2022	25
ASSOCIATION OF EXPANDED MEDICAID COVERAGE TO 12 MONTHS POSTPARTUM WITH CONTRACEPTIVE USE IN SOUTH CAROLINA	24
Money and place: Quantifying the types of obstacles associated with seeking an abortion after 10 weeks’ gestation, 2019–2020	23
The role of advanced training in family planning and reproductive health in a low-income country; the experience of Ethiopia	23
Editorial Board	22
Adolescent and young adult women’s experiences of contraceptive coercion in healthcare interactions in the southern United States	21
Association of body mass index on time to fetal expulsion for individuals undergoing medication abortion over 13 weeks gestational duration	21
GeneFlex—A Chinese generic intrauterine device not to be confused with GyneFix	21
Fetomaternal hemorrhage assessment in Rh-negative patients undergoing dilation and evacuation between 20 and 24 weeks’ gestational age: A retrospective cohort study	20
Over-the-counter oral contraception in the United States: An important opportunity at a time of increased concern about contraceptive access	20
Vomiting and risk of endotracheal intubation related to preoperative doxycycline use for dilation and evacuation	20

EXPERIENCES WITH MEXICO-BASED ABORTION SUPPORT AMONG PEOPLE IN THE US POST-DOBBS	19
ABORTION TRENDS AND METHODS IN GEORGIA OVERALL AND BY GESTATIONAL DURATION, 2010-2022	19
Addendum to “Efficacy of oral levonorgestrel emergency contraception with same day etonogestrel contraceptive implant: A prospective observational study” [Contraception 131 (2024) 110344]	19
EXPLORING TELEMEDICINE USE FOR CONTRACEPTIVE CARE IN US SAFETY-NET CLINICS	18
RACIAL DISCRIMINATION AND PERSON-CENTERED CONTRACEPTIVE CARE IN THE US SOUTHEAST	18
Integrating anti-violence efforts into sexual and reproductive health: Reproductive coercion as a case example	18
Consideration of vasectomy among patients desiring postpartum permanent contraception and their obstetrician-gynecologists: A United States-based study	16
Use of a contraceptive decision support tool in the abortion care setting	16
Fetal tissue donation for research at the time of abortion: A qualitative study of individuals who experienced an abortion in Hawaii in 2018-19	16
Effect of neighborhood-level income on access to emergency contraception	16
Implementing SINC (Self-Identified Need for Contraception) screening: A mixed methods case study	16
The effect of an educational video on knowledge, attitude, and use of contraception in women with systemic lupus erythematosus: A randomized controlled study	15
A pilot quasi-experimental controlled trial of a community-based, multilevel family planning intervention for couples in rural Uganda: evidence of feasibility, acceptability, and effect on contracepti	15
Society of Family Planning Committee Statement: Contraceptive considerations for individuals with cancer and cancer survivors part 1 – Key considerations for clinical care Joint with the Society of Gy	15
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens	15
Socio-behavioral factors linked to willingness to use new male contraceptives: a cross-sectional survey of men and female partners across four low- and middle-income countries	15
“IT DEPENDS ON THE PERSON AND…ON THE SITUATION TOO”: FACTORS INFLUENCING ABORTION METHOD PREFERENCES AMONG BLACK AND LATINX COMMUNITIES IN THE US SOUTHEAST	15
Evaluating the quality and communicative aspects of contraceptive decision aids	15
POST-PLACENTAL LNG-IUD OUTCOMES AT A LARGE COUNTY HOSPITAL IN TEXAS	15
Copyright info/Contents	14
P091Impact of adverse childhood experiences, anxiety, and resilience on pain during office manual uterine aspiration	14
NEIGHBORHOOD-LEVEL RACIALIZED SOCIOECONOMIC DEPRIVATION AND CONTRACEPTIVE USE IN THE US, 2011–2019	14
POSTER ABSTRACTS	14
Changes in contraceptive use during the second COVID-19 lockdown in Brazil: A web-based survey	14
“AY, CÁLLATE, GROSERA. NO DIGAS ESO”: LEARNING ABOUT SEXUALITY AMONG MIDDLE TO OLDER AGE LATINAS IN THE PACIFIC NORTHWEST	14
O18Trends in copper versus hormonal intrauterine device breakage reporting within the us food and drug administration adverse event reporting system	14
HAVE WE EXPANDED ACCESS? THE IMPACT OF ABORTION TELEHEALTH IN A STATE WITH EXTENSIVE REPRODUCTIVE HEALTH DESERTS	14
MOTIVATIONS TO INITIATE AND CONTINUE CONTRACEPTIVE USE AMONG SEXUAL MINORITY YOUNG WOMEN IN THE SOUTHEASTERN US	14
Pharmacist provision of medication abortion: A pilot study	13
P038Ketamine versus fentanyl for surgical abortions: A randomized noninferiority trial	13
Management of cesarean scar ectopic pregnancies at an academic referral center: A case series	13
Society of Family Planning Annual Meeting 2025, scientific abstracts, October 25-27, Pittsburgh, PA	13
Safety testing of Ovaprene: An investigational nonhormonal monthly vaginal contraceptive	13
Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized	12
“So that I can trust them with my body:” How people with low incomes who may become pregnant define and prioritize quality reproductive health care	12
Unintended pregnancy among U.S. military active duty servicemembers: Estimates for 2018 and trends since 2005	12
EMERGENCY CONTRACEPTION AND OVER-THE-COUNTER BIRTH CONTROL AVAILABILITY IN NORTH CAROLINA	12
Society of Family Planning Clinical Recommendation: Prevention of infection after abortion and pregnancy loss	12
Not here, not now: a mystery caller study of availability of mifepristone in community pharmacies in Alberta, Canada	12
Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens	12
Telehealth contraceptive care in 2018: A quality improvement study of barriers to access and patient satisfaction	12
A systematic comparison of implementation strategies at three U.S. clinic settings that expanded access to self-administered injectable contraception	12
Contraceptive care experiences and preferences among Black women in Mississippi: A qualitative study	11
Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel	11
Immediate postpartum contraceptive implant placement and breastfeeding success in postpartum people at risk for low milk supply: A randomized non-inferiority trial	11
A novel approach to cervical dilation for second-trimester dilation and evacuation in a myomatous uterus	11
Improving, expanding, and scaling contraceptive access efforts	10
Health care access and contraceptive use among adult women in the United States in 2017	10
PERINATAL NURSING BEREAVEMENT WORKSHOP - TRAINING FOR CRITICAL PERINATAL PATIENTS	10
Copyright info/Contents	10

P019Illinois patient experiences with public and private insurance coverage for abortion following policy change	10
Dilation and evacuation with transabdominal cerclage in situ for previable preterm prelabor rupture of membranes at 23 weeks gestation	10
Classification of periviable pregnancy-ending interventions for maternal life endangerment as induced abortion	10
P084The role of pediatric subspecialists in adolescent and young adult contraceptive care	10
Transgender, nonbinary, and gender expansive experiences with telehealth medication abortion and implications for health equity in the United States	9
Society of Family Planning Clinical Recommendation: Management of hemorrhage at the time of abortion	9
Patient opinions on sexual and reproductive health services in primary care in rural and urban clinics	9
OPERATIONALIZE REPRODUCTIVE JUSTICE: MODELING COMMUNITY-DRIVEN HEALTHCARE	9
TEMPORARILY WITHDRAWN: Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS12	9
Changes in female permanent contraception at academic medical centers following the Dobbs decision	9
Suspected hepatotoxicity from etonogestrel contraceptive implant: A rare case report	9
DISTANCE TRAVELED TO OBTAIN ABORTION CARE IN SOUTHERN ILLINOIS BEFORE AND AFTER THE DOBBS V JACKSON WOMEN’S HEALTH ORGANIZATION DECISION	9
Patient-controlled intravenous versus on-demand oral, intramuscular or mcs intravenous administration of oxycodone during medical induced abortion from 64 to 128 days of Gestation: A randomized contro	9
O19Experiences of racial/ethnic discrimination and contraceptive use: A longitudinal study	9
How did regional lockdowns during the COVID-19 pandemic affect recruitment into a large multinational cohort study of intrauterine device users?	9
A statewide analysis of uptake of highly effective contraception offered immediately postpartum in Massachusetts, 2017–2021	9
Ohio survey data assessing perceptions of abortion safety	9
Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use	9
Errors in the Society of Family Planning medication management for early pregnancy loss clinical recommendations	9
An exploratory examination of attitudes toward illegal abortion in the U.S. through endorsement of various punishments	9
FUNCTIONAL RECOVERY AFTER SURGICAL UTERINE EVACUATION	9
Postpartum long-acting reversible contraception among privately insured: U.S. National analysis 2007–2016, by term and preterm birth	9
Adherence among a cohort taking progestin-only pills prescribed by a healthcare provider: Results of the BENCHMARK study	9
Decomposition analysis of racial and ethnic differences in receipt of immediate postpartum, long-acting, reversible, and permanent contraception	8
Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol	8
ABORTION PATIENTS’ AWARENESS AND UNDERSTANDING OF AN EARLY PREGNANCY ABORTION BAN AND ACCESS TO IN-STATE CARE	8
Pelvic examination under anesthesia by learners at the time of abortion: Who accepts and who declines?	8
“THAT’S A TRICKY ONE”: ACCESS TO MISOPROSTOL FOR EARLY PREGNANCY LOSS IN RETAIL PHARMACIES ACROSS ARIZONA	8
EVALUATION OF A VIRTUAL “NO TOUCH” ABORTION PROGRAM IMPLEMENTED IN THE GREATER TORONTO AREA DURING THE COVID-19 PANDEMIC	8
P030Interest in rh testing and rho(d) immune globulin received among patients obtaining first-trimester medication abortion through virtual clinics	8
Contraception and nonalcoholic fatty liver disease in women with prior gestational diabetes mellitus	8
Retraction notice to "An integrated analysis of nonmenstrual adverse events with Implanon" [Contraception 58 (1998) S109-S115]	8
ASSESSING THE IMPACT OF HEALTH EQUITY-INFORMED QUALITY IMPROVEMENT ON CONTRACEPTIVE CARE SCREENING, COUNSELING, AND PROVISION	8
P007Accuracy of self-assessment of pregnancy duration eligibility for medication abortion among young people: The advantages of expanding screening questions beyond date of last menstrual period	8
EXPERIENCES OF COST-RELATED DELAYS ACCESSING ABORTION CARE AND PRE-ABORTION PSYCHOLOGICAL WELL-BEING	8
RISK FACTORS FOR SHORT-INTERVAL BIRTHS POST IPP LARC PLACEMENT IN TENNESSEE	8
“The right thing to do would be to provide care… and we can’t”: Provider experiences with Georgia’s 22-week abortion ban	8
Individual, partner, and community variables associated with method-specific contraceptive beliefs in urban and rural Kenya	8
ABORTION TRENDS AT A SINGLE CLINIC IN SOUTHERN ILLINOIS BEFORE AND AFTER THE DOBBS V. JACKSON WOMEN’S HEALTH ORGANIZATION DECISION	8
EXAMINING “BELIEFS” ABOUT ABORTION--WHAT IS ABORTION AND HOW SHOULD ABORTION BE REGULATED: FINDINGS FROM A MULTI-STATE CROSS-SECTIONAL SURVEY.	8
Editorial Board	8
Understanding medication abortion ineligibility due to gestational age among a cohort of patients in Southern California	8
Not actively dying: An inductive categorization of obstetric cases negatively affected by post-Dobbs abortion bans	7
IMMEDIATE ASSESSMENT OF UTERINE ASPIRATE TO EXPEDITE ECTOPIC PREGNANCY DIAGNOSIS	7
Sampling strategies among studies of barriers to abortion in the United States: A scoping review of abortion access research	7
Contraindications to combined hormonal oral contraceptives among over the counter users in the United States	7
PROFESSIONAL IDENTITY FORMATION AS AN ABORTION PROVIDER AMONG BLACK OB-GYN RESIDENTS	7
CREATING A TIME-SENSITIVE DATABASE TO MEASURE STATE-LEVEL OUTPATIENT CONTRACEPTION UTILIZATION IN MEDICAID	7
Drug-drug interactions between antiretrovirals and hormonal contraception: An updated systematic review	7
Beyond pain medication: striving toward more patient-centered placement of intrauterine devices	7
Where do female contraceptive users get their methods, and does this differ by insurance coverage? A state-level examination	7
Racial and ethnic differences in risk for hysterectomy following insertion of a levonorgestrel-releasing intrauterine device: A retrospective cohort study	7
RESIDENTS’ EXPERIENCES OF MORAL DISTRESS IN ABORTION TRAINING	7
Caregivers of youth in foster care in Texas and their role in contraception decision-making for adolescents in care	7
FACTORS ASSOCIATED WITH CHOOSING FETAL PATHOLOGY EXAMS AFTER SECOND-TRIMESTER DILATION AND EVACUATION	7
Lessons learned from the movement behind the first over-the-counter daily birth control pill in the United States and recommended strategies for implementing full insurance coverage	7
URGENT, EMERGENT, OR JUST MISSED? GEOPOLITICAL VARIATIONS IN THE MANAGEMENT OF EARLY PREGNANCY LOSS IN US EMERGENCY DEPARTMENTS	7
An intersectional analysis of contraceptive types chosen among sexual minority women: A nationally representative study	7
Pharmacy deserts: A complexity that worsens contraception access in the United States	7
Retraction notice to “Introduction: Presentation of clinical data on implanon®1” [Contraception 58 (1998) S75−S77]	7
Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone)	7
Bridging the gap: How SiX supports U.S. state legislators in transforming research into policy	7
Editorial: Contraception special issue on the emergence of "FemTech" within the sexual and reproductive health landscape	7
Trajectories of method dissatisfaction among Kenyan women using modern, reversible contraception: A prospective cohort study	7
Copyright info/Contents	7
Beyond stigma: Clinician bias in contraceptive counseling to sexual and gender minority youth	7
EFFICACY AND SAFETY OF THE ESTETROL/DROSPIRENONE ORAL CONTRACEPTIVE IN US STUDY PARTICIPANTS WITH AND WITHOUT OBESITY	7
Factors associated with postpartum contraceptive planning in New Zealand	7
Effectiveness, safety, and acceptability of postplacental insertion of GyneFix postpartum intrauterine device among women undergoing cesarean section: A multicenter prospective cohort study in China	7
WHY US MEN HAVE ABORTIONS: QUANTITATIVE AND QUALITATIVE PERSPECTIVES FROM URBAN FAMILY PLANNING CLINICS	6
P022Growing national interest and support for advance provision and over-the-counter access to medication abortion	6
IMPACT OF BLEEDING ON SATISFACTION AND CONTINUATION AMONG ADOLESCENT IMPLANT USERS	6
Testing the validity and reliability of the Person-Centered Contraceptive Counseling (PCCC) Performance Measure in a Real-World Contraceptive Access Program	6
Male contraception – Part of gender medicine and reproductive rights of men	6
LEGAL UNCERTAINTY AND THE CHILLING EFFECT OF ABORTION BANS ON CLINICAL CARE	6
EXPLORING THE IMPACTS OF DOBBS DECISION ON ABORTION TRAINING AT RYAN PROGRAMS	6
Remote Provision and Self-Administration of Misoprostol as Cervical Preparation for Hospital-Based Uterine Evacuation Between 14-18 Weeks	6
CONCURRENT ADMINISTRATION OF DEPOT MEDROXYPROGESTERONE ACETATE WITH MIFEPRISTONE MAY DECREASE MEDICATION ABORTION EFFICACY: A RETROSPECTIVE COHORT STUDY	6
Impact of new abortion restrictions on people in prison: Estimated number of incarcerated people without abortion access and distance to abortion providers	6
Use of PROMIS Global-10 to measure changes in health-related quality of life among contraceptive initiators: A feasibility study	6

VARIATION IN OB-GYN RESIDENTS’ ABORTION-RELATED SKILLS	6
“That is when I understood everything”: Ideological trajectories of pro-choice female doctors in Mexico	6
Ally, the pioneering abortion chatbot: Capturing regional variations in self-managed abortion needs	6
PREGNANCY OPTIONS CONSIDERED AMONG NEWLY PREGNANT PEOPLE IN THE SOUTHWEST US	6
P056Oral contraceptive adherence and pregnancy rates in estetrol/drospirenone pooled phase 3 trials	6
P064Depression after 12-month use of oral or intrauterine contraception	6
Featured research at the 2023 Society of Family Planning Annual Meeting	6
TEXAS MINORS’ USE OF TITLE X SERVICES FOLLOWING A LOSS OF CONFIDENTIALITY PROTECTIONS	6
Corrigendum to “Participation in an HIV prevention intervention and access to and use of contraceptives among young women: A cross-sectional analysis in six South African districts” [Contraception 116	6
PATIENT PERSPECTIVES ON OUT-OF-STATE TRAVEL FOR ABORTION CARE POST-DOBBS	6
ASSESSING QUALITY OF CONTRACEPTIVE COUNSELING AT A POPULATION LEVEL: AN OPPORTUNITY TO INFORM EQUITABLE CARE DELIVERY	6
P068Navigating uncertainty: (In)fertility and reproductive planning	6
IMPROVING ESTIMATES OF MEDICATION ABORTION EFFECTIVENESS: THE IMPACT OF LOSS TO FOLLOW-UP	6
Racial and ethnic disparities in short interval pregnancy following delivery in Catholic vs non-Catholic hospitals among California Medicaid enrollees	5
O17Immediate postpartum contraceptive implant placement and breastfeeding success in women at risk for low milk supply: A randomized non-inferiority trial	5
Disparities in perceptions of long-acting reversible contraceptives among patients in Delaware Title X clinics	5
Helping patients choose between pain control options for outpatient procedural abortion at less than 12 weeks' gestation	5
Infected products of conception in obstructed hemivagina after medical management of early pregnancy loss: A case report	5
Healthcare provider communication and current contraceptive use among transgender men and gender-diverse people: Results from an online, cross-sectional survey in the United States	5
ONGOING CONTRACEPTIVE GOALS FOR PATIENTS WHO DO NOT ACHIEVE DESIRED POSTPARTUM PERMANENT CONTRACEPTION PRIOR TO HOSPITAL DISCHARGE	5
State-level contraceptive access policies and preventive sexual and reproductive health service use outcomes	5
Factors associated with a negative Patient Acceptable Symptom State (PASS) response with intrauterine device placement: A retrospective survey of HER Salt Lake participants	5
Intrauterine device self-removal practices during the COVID-19 pandemic among family planning clinics	5
LEVONORGESTREL 52 MG INTRAUTERINE DEVICE PLACEMENT WITHOUT SOUNDING: A FEASIBILITY STUDY	5
ESTIMATING EMERGENCY CONTRACEPTION EFFICACY WITH LEVONORGESTREL AND COPPER INTRAUTERINE DEVICES	5
“I would just take it whenever I felt like it”: A qualitative study of women’s contraceptive knowledge, attitudes, and practices in Algeria	5
Copyright info/Contents	5
The experience of pain in real-time during medication abortion	5
P092Measuring utilization of mifepristone in medication management of missed abortions: Retrospective claims analysis study	5
Hair cortisol/cortisone in combined oral contraceptive users: An exploratory analysis	5
Response to Dr. Winter's letter	5
Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the U.S.	5
Telemedicine for medical abortion service provision in Mexico: A safety, feasibility, and acceptability study	5
Editorial Board	5
Accessibility of oral emergency contraceptives in Australian community pharmacies	5
Procedural abortion in individuals with opioid dependence: Patient characteristics and pain experience	5
Reshaping access: Community-led action for contraceptive access in rural Appalachian Kentucky	5
“I’M NOT SOMEONE WHO WOULD EVER HAVE AN ABORTION”: MANAGING ABORTION STIGMA AFTER DIAGNOSIS OF A SEVERELY MORBID OR LETHAL FETAL CONDITION	5
Clinical interventions are more accurate than quantitative measurements for defining hemorrhage with dilation and evacuation	5
Exploring the availability and accessibility of medication abortion pills in Nepal pharmacies: Reported versus actual provision practices	5
ASSOCIATION BETWEEN EXPERIENCES OF DISCRIMINATION AND CONCERNS ABOUT ACCESSING CONTRACEPTIVE CARE AMONG COMMUNITY COLLEGE STUDENTS IN TEXAS AND CALIFORNIA	5
PUBLIC SUPPORT FOR REPORTING AND PUNISHING PEOPLE WHO USE ALCOHOL OR DRUGS WHILE PREGNANT	5
Changes in the provision of hospital-based second-trimester uterine evacuation post-Dobbs in a consistently abortion-restrictive state	5
Society of Family Planning Research Practice Support: Approaching the concepts of gender and sex in family planning research	5
Estetrol/Drospirenone safety in a population with cardiovascular risk factors	5
Replicating the use of motivational interviewing and facilitated contraceptive access to reduce repeat adolescent pregnancy: A randomized trial	5
Retraction notice to “Effect of cervical lidocaine-prilocaine cream on pain perception during copper T380A intrauterine device insertion among parous women: a randomized double-blind controlled trial”	5
Understanding the mechanical behavior of intrauterine devices during simulated removal	5
Catholic sole community hospitals are associated with decreased receipt of postpartum permanent contraception among Medicaid recipients	5
Assessment of adolescent decision-making capacity for pharmacy access to hormonal contraception	5
Effectiveness and safety of a direct-to-patient telehealth service providing medication abortion targeted at rural and remote populations: Cross-sectional findings from Marie Stopes Australia	5
Effectiveness and safety of medication abortion via telemedicine versus in-person: A cohort of pregnant people in Colombia	5
Evaluating the accuracy of CPT coding for inpatient second- and third-trimester labor induction abortion at a tertiary medical center	5
REPORTED ABORTION TRAINING OPPORTUNITIES AMONG TEXAS PGY-1 OB-GYN RESIDENTS AFTER THE FALL OF ROE	5
Providing family planning counseling services for women with chronic medical conditions in an inpatient setting: A randomized feasibility trial	5
P079Etonogestrel contraceptive implant users can experience breakthrough ovulation with only two weeks of exposure to a strong cyp3a inducer	5
IMMEDIATE POSTPARTUM STERILIZATION AFTER VAGINAL DELIVERY IN THE PRE-COVID AND COVID PERIODS IN NEW YORK	5
Association of perinatal depression and postpartum contraception intent, choice, and actual use	5
Editorial Board	5
Association of willingness to use hormonal contraception with knowledge: A national survey	5
WHAT INFORMATION DO PEOPLE NEED TO SUPPORT SELF-MANAGED GENDER AFFIRMING HORMONE THERAPY (GAHT) IN THE US? A QUALITATIVE EXPLORATION OF REDDIT POSTS	5
Provider perspectives on patient-centered contraceptive counseling for Latinas in Baltimore, MD	5
Editorial Board	5
Society of Family Planning clinical recommendations: Contraception and abortion care for persons who use substances	5
P090Perceptions of hiv risk screening strategies among patients seeking abortion, contraception, and pregnancy loss management	5
One-year continuation of the etonogestrel contraceptive implant initiated with oral emergency contraception	5
An examination of loss to follow-up and potential bias in outcome ascertainment in a study of direct-to-patient telemedicine abortion in the United States	4
Effects of aromatherapy on patient satisfaction with procedural abortion at less than 10 weeks’ gestation: A randomized controlled trial	4
Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation	4
Temporal trends in contraceptive use in British Columbia, Canada between 2001 and 2021: a descriptive analysis	4
Copyright info/Contents	4
Editorial Board	4
CHANGE IN CLINIC VOLUME AND GESTATIONAL AGE AT TIME OF ABORTION IN SOUTHERN ILLINOIS BEFORE AND AFTER DOBBS V JACKSON WOMEN’S HEALTH ORGANIZATION	4
The association of patient age, race, and demographic features on reported pain and sedation dosing during procedural abortion: A retrospective cohort study	4
Amenorrhea in adolescents using the etonogestrel contraceptive implant	4
Do miscarriage care practice recommendations align with individuals’ needs?: A scoping review	4
A double-blind, triple-arm randomized controlled trial of 1% lidocaine paracervical block for intrauterine device (IUD) insertion	4
A new vision for male contraception research and development	4
PHARMACY PRESCRIBING IS ALLOWED; WHY ISN’T IT HAPPENING?	4
Building the capacity of young professionals in family planning to publish: Insights from the ICFP2022 WHO scientific writing, mentoring and coaching course	4
Unanswered questions from abortion seekers: An application of the Research Prioritization by the Affected Community (RPAC) protocol in the Central Valley, California	4
P003“We are completely captured”: The influence of us foreign policy through the global gag rule on malawi's sexual and reproductive health and rights landscape	4
Language-based acculturation is linked with reproductive autonomy among Oregon Mexican-origin Latinas	4
One year of Opill: Retail sales of over-the-counter birth control pills in the United States	4
Participation in an HIV prevention intervention and access to and use of contraceptives among young women: A cross sectional analysis in six South African districts	4
Virtual reality simulation in reducing discomfort and pain during intrauterine device insertion: a randomized controlled trial	4
Understanding support needs for people carrying pregnancies with life-limiting fetal conditions: a qualitative study	4
Copyright info/Contents	4
Clinical outcomes of medication abortion using misoprostol-only: A retrospective chart review at an abortion provider organization in the United States	4
Response to: "Contraceptive safety in liver disease: The cost of overstating risk"	4
Acceptability and challenges of self-removal of intrauterine devices in Campinas, Brazil	4
P083The impact of federal and state-level contraceptive coverage policies on contraceptive cost and use among privately insured women	4
Effectiveness of training primary care internal medicine residents in etonogestrel implants and impact on their future practice: A cross-sectional study	4
Supporting Self-Managed Medication Abortion: Care Needs and Preferences of SMMA Users in Three US States	4
An opportunity for guidance on reproductive health tracking technologies in a post-Roe United States	4